Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CSL Behring
CSL Behring Seeking Proposals for LEAD Grants to Support Patient Advocacy Efforts
April 18th, 2009
CSL Behring (ASX:CSL), a global leader in the plasma-protein biotherapeutics industry, is calling for grant requests through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program awards funds to United States patient organizations that assist people with rare diseases in advocating for continued access to health care and life-saving plasma protein therapies. To date, the LEAD program has awarded more than $150,000 to 12 patient organizations for their use in funding grassroots advocacy initiatives that mobilize patient populations to advance state standards of care legislation and improve access to health insurance. “CSL...
Source: Law & Health Weekly (2009-04-18)
|
